Medivis, a New York based technology firm specialising in the development of AR data visualisation and integration, has released its very first product following a two-year development phase.
Christopher Morley and Osamah Choudhry, the founders of the company, had met each other at the NYU Medical Center as senior-level residents.
Morley and Choudhry started the platform as a side-project during the early days. The two residents brought in engineering professionals for the purpose of prototype developments. Following their venture into the NYU Summer Launchpad program, Medivis was launched by the duo.
The company is launching its first product named SurgicalAR with support provided by Dell, hardware from Microsoft, and funding of $2.3 million coming from parties including Initialized Capital.
According to Morley, the launch of HoloLens was a propeller for the ambitions of Medivis. He elaborated that the augmented reality technology helped in creating new pathways for the implementation of advanced technology in the medical domain. He remarked that the ability to render patients holographically was a major breakthrough.
Augmented reality technology helped in creating new pathways for the implementation of advanced technology in the medical domain. – Christopher Morley
Medivis currently holds the capacity to obtain patient-related data and create three-dimensional visual representation models. Such models can be utilised as references by doctors to create surgery plans. All models can be traced back to patients to help surgeons make decisions regarding the ideal approaches for operations.
He is of the belief that there is a lot of room for innovation in the field of medical imaging, to make the technology even more helpful in improving surgical procedures.
Medivis has worked with New York University and the University of Pennsylvania to introduce their prototypes for surgery purposes.
The firm is now in the process of implementing machine learning features to detect and determine information relating to the medical records of patients, along with diagnostics for initiating surgery planning procedures.
According to Morley, the company has put in efforts to develop a disruptive three-dimensional channel. Realising the acute lack of three-dimensional pipelines for direct interfacing, and for automating the full rendering process.
Medivis currently sells a touchscreen monitor, headset and display. Choudhry revealed that the device is able to utilise a hospital’s network to extract medical images from servers for display purpose, within a time span of 30 seconds.
Choudhry stated that the development can become useful instantly if implemented during the pre-surgery planning phase. Planning and the creation of surgical navigation extension are aspects which require processing of various setups and components. According to Chaudhry, the process can be simplified and streamlined with the use of an augmented reality headset, which enables pathology localisation and decision making.
The company has already performed fifteen successful surgeries with the technology.
Eric Woersching, a general partner at Initialized Capital, offered his insights regarding the development. He was able to recognise the nature and scale of problems faced by Morley and Chaudhry, on meeting up with them. Woersching, being aware of the lack of medical imaging implementation, applauded the innovative expertise of Medivis and decided to fund the company’s project.
